Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Evelo Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −5 vs. Q2 2022
- Shares held
- 86.1M
- +631.7K (+0.7%) vs. Q2 2022
- Total value
- $180.0M
- −$383.3K (−0.2%) vs. Q2 2022
- New holders
- 6
- 10 more added
- Sold out
- 11
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 50,427,328 | $105.4M | 4.44% | 00.0% | Unchanged |
| FMR LLC | 16,199,055 | $33.9M | 0.00% | +13,346+0.1% | Added |
| State of Michigan Retirement System | 4,070,728 | $8.51M | 0.06% | 00.0% | Unchanged |
| Credit Suisse AG | 3,670,178 | $7.67M | 0.01% | −4,547−0.1% | Reduced |
| Vanguard Group Inc | 3,222,420 | $6.74M | 0.00% | +1,862,098+136.9% | Added |
| HarbourVest Partners LLC | 3,063,505 | $6.40M | 2.09% | 00.0% | Unchanged |
| CVI Holdings, LLC | 1,693,655 | $3.54M | 0.27% | −361,139−17.6% | Reduced |
| BlackRock Inc. | 1,205,366 | $2.52M | 0.00% | +294,413+32.3% | Added |
| Alphabet Inc. | 1,060,495 | $2.22M | 0.11% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 586,483 | $1.23M | 0.00% | +239,757+69.1% | Added |
| Millennium Management LLC | 184,663 | $386.0K | 0.00% | −8,471−4.4% | Reduced |
| State Street Corp | 113,858 | $238.0K | 0.00% | +19,700+20.9% | Added |
| Bridgeway Capital Management, LLC | 105,300 | $220.0K | 0.01% | +105,300 | New |
| Northern Trust Corp | 95,272 | $199.0K | 0.00% | +23,137+32.1% | Added |
| Morgan Stanley | 64,325 | $134.0K | 0.00% | −75,238−53.9% | Reduced |
| Bessemer Group Inc | 61,289 | $128.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 48,706 | $102.0K | 0.00% | +20,465+72.5% | Added |
| Goldman Sachs Group Inc | 34,065 | $71.0K | 0.00% | −7,974−19.0% | Reduced |
| Charles Schwab Investment Management Inc | 31,345 | $66.0K | 0.00% | −87,922−73.7% | Reduced |
| Ergoteles LLC | 27,429 | $57.0K | 0.00% | −276,900−91.0% | Reduced |
| Occudo Quantitative Strategies LP | 25,346 | $53.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 19,677 | $41.0K | 0.00% | −11,083−36.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 19,100 | $40.0K | 0.00% | −200−1.0% | Reduced |
| Cresset Asset Management, LLC | 18,366 | $38.0K | 0.00% | −1,634−8.2% | Reduced |
| Susquehanna International Group, LLP | 17,973 | $38.0K | 0.00% | +17,973 | New |
| Bank of New York Mellon Corp | 13,150 | $27.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 11,082 | $23.0K | 0.00% | −11,757−51.5% | Reduced |
| LMR Partners LLP | 10,833 | $23.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7,208 | $15.0K | 0.00% | +2,142+42.3% | Added |
| Citigroup Inc | 6,140 | $13.0K | 0.00% | +4,208+217.8% | Added |
| Tower Research Capital LLC (TRC) | 5,285 | $11.0K | 0.00% | −667−11.2% | Reduced |
| Barclays PLC | 3,002 | $6.00K | 0.00% | +3,002 | New |
| UBS Group AG | 2,612 | $5.00K | 0.00% | +2,612 | New |
| Fairfield Financial Advisors, LTD | 1,075 | $2.25K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 739 | $2.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,011 | $2.00K | 0.00% | +1,011 | New |
| BNP Paribas Arbitrage, SA | 648 | $1.35K | 0.00% | −3,025−82.4% | Reduced |
| Wells Fargo & Company | 380 | $1.00K | 0.00% | +197+107.7% | Added |
| National Bank of Canada | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 156 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 144 | $0 | 0.00% | +144 | New |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −342,465−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −294,242−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −200,417−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −107,423−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −56,029−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,252−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,500−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −26,116−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −26,300−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −19,205−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −265−100.0% | Sold out |